Viewing StudyNCT00325130



Ignite Creation Date: 2024-05-05 @ 4:50 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00325130
Status: COMPLETED
Last Update Posted: 2015-03-12
First Post: 2006-05-11

Brief Title: Concomitant Use of Gardasil V501 Human Papillomavirus Types 6 11 16 18 Recombinant Vaccine With Combined Diphtheria Tetanus Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents V501-025
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Organization Data

Organization: Merck Sharp Dohme LLC
Class: INDUSTRY
Study ID: V501-025
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Merck Sharp Dohme LLC
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators